Skip to content

← All news

Markets

Pulmovant’s mosliciguat meets phase 2 trial endpoints in PH-ILD

1 source ·2 articles ·Sep 8, 10:06 UTC Parker-Hannifin

Covered by 1 outlet

All coverage · 2 articles

Investing.com Canada ·Sep 8, 10:06 UTC

Pulmovant’s mosliciguat meets phase 2 trial endpoints in PH-ILD

Investing.com News ·Sep 8, 10:04 UTC

Pulmovant’s mosliciguat meets phase 2 trial endpoints in PH-ILD